Geneva Partners, LLC Merck & Co., Inc. Transaction History

Geneva Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$123.8 - $132.96 $117,733 - $126,444	951 Added 4.7%	21,165 $2.62 Million
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $33,972 - $39,585	-300 Reduced 1.46%	20,214 $2.67 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $2.14 Million - $2.33 Million	-21,390 Reduced 51.05%	20,514 $2.24 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $840,998 - $933,961	-8,169 Reduced 16.31%	41,904 $4.31 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $127,399 - $138,859	-1,173 Reduced 2.29%	50,073 $5.78 Million
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $217,615 - $242,814	-2,114 Reduced 3.96%	51,246 $5.45 Million
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $4.22 Million - $5.41 Million	48,259 Added 946.07%	53,360 $0
Q3 2022 Oct 31, 2022	BUY	$84.53 - $94.96 $431,187 - $484,390	5,101 New	5,101 $439,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.